Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.1K
Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Hazard Ratio01:12

Hazard Ratio

659
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
659
Blinding01:11

Blinding

4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

338
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
338

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer.

Frontiers in endocrinology·2023
Same author

Numerical investigation of localization in two-dimensional quasiperiodic mosaic lattice.

Journal of physics. Condensed matter : an Institute of Physics journal·2023
Same author

Determination Methods of the Risk Factors in Food Based on Nanozymes: A Review.

Biosensors·2023
Same author

Mid-infrared single photon detector with superconductor Mo<sub>0.8</sub>Si<sub>0.2</sub> nanowire.

Science bulletin·2023
Same author

Succulent-plant-like Ni-Co alloy efficient catalysts for direct borohydride fuel cells.

Dalton transactions (Cambridge, England : 2003)·2023
Same author

Age-level bias correction in brain age prediction.

NeuroImage. Clinical·2023

Related Experiment Video

Updated: Feb 27, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Empirical likelihood inference in randomized clinical trials.

Biao Zhang1

  • 1Department of Mathematics and Statistics, The University of Toledo, Toledo, USA.

Statistical Methods in Medical Research
|July 7, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces an empirical likelihood method for covariate adjustment in randomized controlled trials. This approach enhances the precision and power of treatment effect estimates, even when regression models are misspecified.

Keywords:
Average treatment effectclinical trialcovariate adjustmentefficiencyempirical likelihoodinfluence functionrandomizationregressionunbiased estimating function

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Related Experiment Videos

Last Updated: Feb 27, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Statistical Inference

Background:

  • Randomized controlled trials (RCTs) often collect pre-randomization covariate data.
  • Covariate adjustment in regression models is commonly used to increase the precision of average treatment effect (ATE) estimates.
  • Concerns exist regarding potential compromises to objective inference in RCTs due to covariate adjustment.

Purpose of the Study:

  • To propose an empirical likelihood approach for covariate adjustment in RCTs.
  • To develop unbiased estimating functions that separate ATE estimation from covariate-outcome modeling.
  • To evaluate the efficiency and robustness of the proposed method compared to existing techniques.

Main Methods:

  • Developed an empirical likelihood framework for covariate adjustment.
  • Proposed two unbiased estimating functions decoupling ATE and covariate-outcome relationships.
  • Conducted a simulation study to compare finite sample performance.
  • Analyzed data from an HIV clinical trial.

Main Results:

  • The empirical likelihood estimator achieves efficiency comparable to existing adjusted estimators when regression models are correctly specified.
  • The proposed estimator remains at least as efficient as existing methods regardless of working model specification.
  • Simulation results show the empirical likelihood approach is more efficient and powerful when covariate-outcome relationships are misspecified.

Conclusions:

  • The proposed empirical likelihood method offers a robust and efficient approach to covariate adjustment in RCTs.
  • This method enhances statistical power and precision, particularly when regression models are misspecified.
  • The approach provides reliable inference for average treatment effects in the presence of baseline covariates.